By Region

Regional Surveillance and Research Programs

PneumoADIP supports surveillance networks and multiple, small grants projects in Africa, The Americas, and Asia.

Pneumococcal data from the developing world, particularly Africa and Asia, has historically been very limited. Prior to 2003 and support from PneumoADIP, there were few surveillance sites located in GAVI-eligible countries. These are precisely the countries that are in most need of reliable pneumococcal data because they are the countries who have the most to gain from pneumococcal vaccine introduction. In addition, the data that was available was rarely representative of an entire country or region and usually was not comparable to data from other regions because non-standard clinical definitions were often used.

Through its surveillance activities, PneumoADIP has greatly increased the number of developing, GAVI-eligible countries producing high-quality pneumococcal data. Data is collected in a standardized manner with common clinical diagnostic algorithms and laboratory protocols. Through the use of networks spanning countries and regions and including both hospital- and community-based surveillance, PneumoADIP strives to generate data that expands representativeness and improves the comparability of pneumococcal surveillance across a country or region and between regions. Ensuring data comparability between countries and regions enables the estimation of disease burden in areas without ongoing surveillance activities by creating models and extrapolating results. Additional benefits of networking surveillance projects include intra- and cross-network peer pressure to improve quality, ease of communication of findings across borders, promotion of best practice sharing, and south-south collaborations.

PneumoADIP’s Small Grants Program supports small projects across the globe. These projects are diverse and include pneumococcal surveillance activities, projects focused on assessing the short- and long-term disability and developmental consequences of pneumococcal disease, and research to estimate the costs to families and health systems of treating pneumococcal disease. The studies aim to establish evidence-based messages about pneumococcal vaccines for informing health professionals and assess risk factors for pneumococcal disease. The Small Grants Program enables broader geographic involvement and a greater variety of projects than is possible by other means. Small grants can represent a significant investment in developing countries - achieving significant results in a short time and sowing the seeds for larger projects. In many cases, data from different projects may be complementary, acting as pieces of a puzzle that develop into a bigger picture. All of these activities work to further PneumoADIP’s mission to accelerate the evaluation of and access to pneumococcal vaccines for those who are most in need.

To learn more about pneumoADIP’s regional surveillance networks and small grants programs please select a region below:

Africa

The netSPEAR surveillance network is a collaboration that includes surveillance in seven countries: Burundi, Eritrea, Ethiopia, Kenya, Tanzania, Uganda, and Rwanda.

PneumoADIP has sponsored Small Grants Projects in Burkino Faso, Ghana, Kenya, Mali, Mozambique, Nigeria, South Africa, Tanzania, and Togo.

The Americas

The SIREVA II surveillance network is a collaboration that includes surveillance in 20 countries in the Americas. SIREVA II+ is a smaller network of six SIREVA II countries (Brazil, Columbia, Dominican Republic, Guatemala, Nicaragua, and Uruguay) that collect a higher proportion and more in depth data to improve accuracy and generalizability.

PneumoADIP has sponsored Small Grants Projects in Dominican Republic and Guatemala.

Asia

There are six different regional networks that work collecting, analyzing, and distributing data in 14 countries in Asia and the Eastern Mediterranean region.

PneumoADIP has sponsored Small Grants Projects in Bangladesh, Egypt, Fiji, India, Indonesia, Jordan, Lebanon, Pakistan, and Viet Nam.